Cargando…
Ex vivo analysis platforms for monitoring amyloid precursor protein cleavage
Alzheimer’s disease (AD) is a progressive neurodegenerative brain disorder and the most common cause of dementia in the elderly. The presence of large numbers of senile plaques, neurofibrillary tangles, and cerebral atrophy is the characteristic feature of AD. Amyloid β peptide (Aβ), derived from th...
Autores principales: | Kamikubo, Yuji, Jin, Hao, Zhou, Yiyao, Niisato, Kazue, Hashimoto, Yoshie, Takasugi, Nobumasa, Sakurai, Takashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9852844/ https://www.ncbi.nlm.nih.gov/pubmed/36683852 http://dx.doi.org/10.3389/fnmol.2022.1068990 |
Ejemplares similares
-
TMEM30A is a candidate interacting partner for the β-carboxyl-terminal fragment of amyloid-β precursor protein in endosomes
por: Takasugi, Nobumasa, et al.
Publicado: (2018) -
The Pursuit of the “Inside” of the Amyloid Hypothesis—Is C99 a Promising Therapeutic Target for Alzheimer’s Disease?
por: Takasugi, Nobumasa, et al.
Publicado: (2023) -
Galectin 3–binding protein suppresses amyloid-β production by modulating β-cleavage of amyloid precursor protein
por: Seki, Tsuneyoshi, et al.
Publicado: (2020) -
Dimerization of the transmembrane domain of amyloid precursor protein is determined by residues around the γ-secretase cleavage sites
por: Yan, Yan, et al.
Publicado: (2017) -
Lipid flippase dysfunction as a therapeutic target for endosomal anomalies in Alzheimer’s disease
por: Kaneshiro, Nanaka, et al.
Publicado: (2022)